Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study

NCT05638321 is registered in ClinicalTrials.gov with Sanoculis Ltd as lead sponsor.

NCT NCT05638321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study
Lead sponsor
Sanoculis Ltd
Phase
Not applicable
Overall status
Completed
Start date
April 11, 2022
Completion date
March 12, 2024
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

this study is conducted under inclusion/ exclusion criteria